The Which Heart failure Intervention is most Cost-effective in reducing Hospital stay (WHICH? II) trial.

Not Applicable

Completed

• Conditions: Heart Failure; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12613000921785
• Lead Sponsor: Professor Simon Stewart

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-08-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

Individuals discharged to home following an admission to a participating hospital will be eligible for study randomisation if they: 1) have a diagnosis of chronic heart failure and 2) a history of 1 or more admissions to hospital with acute HF (including the index hospitalisation).

Exclusion Criteria

Patients will be excluded if they have a terminal condition, are non-English speaking and unable to give fully informed consent (in the absence of an interpreter) and/or unable to give fully informed consent for another reason.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total cost of health care (calculated as cost/day per subject). Assessed via linked data from hospital/death records, GP follow-up and participant feedback.[12 Months post index hospital discharge]